Record Exits and Realizations
EQT delivered its most active exit year ever with total realizations of EUR 34 billion in 2025 (includes EUR 19+ billion of fund exits, ~70% higher than prior year, plus EUR 14 billion realized for co-investors). Notable single-asset outcome: Galderma generated >EUR 9 billion of proceeds in 2025 and has produced >USD 20 billion in capital gains to date. The equity strategy returned close to 30% of NAV to investors (~3x industry average).
Strong Investment Activity and Co-Invest Program
EQT invested EUR 16 billion across strategies in 2025 and facilitated approximately EUR 14 billion of co-investment opportunities for clients (co-invest ratio close to 1:1). Co-invest facilitation increased from EUR 12 billion in 2024 to EUR 14 billion in 2025 (~16.7% increase).
Fundraising Momentum — Gross Inflows More Than Doubled
Gross inflows more than doubled year-over-year to EUR 26 billion. Key fund progress includes BPEA IX at USD 14 billion raised to date (expected to close at a USD 14.5 billion hard cap), Healthcare Growth and Transition Infrastructure fundraising of ~EUR 3 billion combined, and evergreens/institutional open-ended launches with ~EUR 2 billion of evergreen inflows and NAV of ~EUR 3.5 billion by year-end.
Revenue and Fee-Related Profitability Growth
Total revenue grew 16% in 2025. Fee-related revenues increased by 9% and EQT reported a fee-related EBITDA margin of 52% in 2025 (management aims to reach 55%+ at completion of the current fundraising cycle). Carried interest and investment income rose to EUR 448 million, and EUR 1.3 billion of carried interest has been recognized to date from the four funds in carry mode.
Fund Performance and Valuation Upside
Key fund valuations rose by 8% on an FX-neutral basis in 2025. The latest generation of key funds increased by 15% excluding FX. Four out of five funds raised in 2019 or earlier are performing above plan; 2020–2021 vintages are largely generating 10%+ value creation (FX-neutral).
Strategic Acquisition of Coller Capital to Enter Secondaries
Agreement reached to acquire Coller Capital: base consideration of USD 3.2 billion funded in newly issued EQT shares plus contingent consideration up to USD 500 million (dependent on high‑20s fee‑related revenue growth to 2029). EQT will be entitled to 35% of carry in future Coller funds and acquires 10% of carry in Coller Private Equity Fund IX. Closing expected in Q3 2026.
Scale and AUM Expansion from Coller Combination
Coller adds ~EUR 28 billion of fee-paying AUM and ~EUR 42 billion of total AUM; combined firm AUM expected to be ~EUR 312 billion. Coller’s Fund IX (private equity secondaries) closed at USD 10.2 billion (up >35% vs prior generation); Coller private credit secondaries funds total ~USD 5 billion; evergreen momentum with NAV >USD 4 billion and inflows ~USD 200 million/month.
Shareholder Returns and Capital Actions
Board proposes dividend of SEK 5 per share for 2025, representing 16% growth. During 2025, EQT distributed ~EUR 460 million in dividends and repurchased ~EUR 300 million of shares.